Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
ABSTRACT Recent studies have linked proton pump inhibitor (PPI) treatment to increased complications of cirrhosis, such as bacterial infections and hepatic encephalopathy. However, the underlying pathophysiological mechanisms remain unclear. The present study investigated the hypothesis that PPI tre...
| Published in: | mBio |
|---|---|
| Main Authors: | Lukas Sturm, Misa Hirose, Laura Stolz, Michael Schultheiss, Katharina Zoldan, Marlene Reincke, Jan Patrick Huber, Rafael Kaeser, Tobias Boettler, Robert Thimme, Elisabeth Albert, Hauke Busch, Axel Künstner, Dominik Bettinger |
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2023-10-01
|
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/mbio.00492-23 |
Similar Items
Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
by: Lukas Sturm, et al.
Published: (2022-01-01)
by: Lukas Sturm, et al.
Published: (2022-01-01)
Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis
by: Kseniya Gulyaeva, et al.
Published: (2025-03-01)
by: Kseniya Gulyaeva, et al.
Published: (2025-03-01)
Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis
by: Ping Qi, et al.
Published: (2025-06-01)
by: Ping Qi, et al.
Published: (2025-06-01)
The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2012-09-01)
by: M. S. Zharkova, et al.
Published: (2012-09-01)
Portal vein thrombosis in patients with liver cirrhosis
by: Savić Željka, et al.
Published: (2024-01-01)
by: Savić Željka, et al.
Published: (2024-01-01)
A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
by: Michele Fiordaliso, et al.
Published: (2023-10-01)
by: Michele Fiordaliso, et al.
Published: (2023-10-01)
Progressive systemic inflammation precedes decompensation in compensated cirrhosis
by: Rubén Sánchez-Aldehuelo, et al.
Published: (2025-02-01)
by: Rubén Sánchez-Aldehuelo, et al.
Published: (2025-02-01)
Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis
by: Roberto Cangemi, et al.
Published: (2024-01-01)
by: Roberto Cangemi, et al.
Published: (2024-01-01)
Portal-systemic by-pass and the analysis of survival rate research resultsin patients with liver cirrhosis
by: F. G. Nazyrov, et al.
Published: (2007-09-01)
by: F. G. Nazyrov, et al.
Published: (2007-09-01)
Diagnosis and Management of Portal Vein Thrombosis in Liver Cirrhosis
by: Cynthia Kurniawan, et al.
Published: (2025-04-01)
by: Cynthia Kurniawan, et al.
Published: (2025-04-01)
Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study
by: Yoo Li Lim, et al.
Published: (2017-09-01)
by: Yoo Li Lim, et al.
Published: (2017-09-01)
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis
by: B.V. John, et al.
Published: (2013-11-01)
by: B.V. John, et al.
Published: (2013-11-01)
Transient portal vein thrombosis in liver cirrhosis
by: Xingshun Qi, et al.
Published: (2018-06-01)
by: Xingshun Qi, et al.
Published: (2018-06-01)
Surgical treatment of portal hypertension complications in patients with liver cirrhosis
by: V. M. Durleshter, et al.
Published: (2022-09-01)
by: V. M. Durleshter, et al.
Published: (2022-09-01)
Combined bacterial translocation and cholestasis aggravates liver injury by activation pyroptosis in obstructive jaundice
by: Xin Shen, et al.
Published: (2024-08-01)
by: Xin Shen, et al.
Published: (2024-08-01)
Effect of Propranolol on Portal Pressure and Systemic Hemodynamics in Patients with Liver Cirrhosis and Portal Hypertension: A Prospective Study
Published: (2007-12-01)
Published: (2007-12-01)
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01)
by: D. V. Garbuzenko
Published: (2018-11-01)
A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)
by: Fiona J. Gifford, et al.
Published: (2020-03-01)
by: Fiona J. Gifford, et al.
Published: (2020-03-01)
A new model of portal vein thrombosis in rats with cirrhosis induced by partial portal vein ligation plus carbon tetrachloride and intervened with rivaroxaban
by: Yanan Guo, et al.
Published: (2024-05-01)
by: Yanan Guo, et al.
Published: (2024-05-01)
Bibliotheken und Portale - ein Überblick / Libraries and portals - a survey
by: Guba, Beate
Published: (2006-09-01)
by: Guba, Beate
Published: (2006-09-01)
MODERN APPROACHES AND PRINCIPLES OF PORTAL BUILDING
by: Natalia T. Zadorozhna, et al.
Published: (2010-09-01)
by: Natalia T. Zadorozhna, et al.
Published: (2010-09-01)
Possibilities of the help to patients with the cirrhosis complicated by portal hypertensia
by: E. V. Svetova, et al.
Published: (2018-03-01)
by: E. V. Svetova, et al.
Published: (2018-03-01)
Portal vein thrombosis in liver cirrhosis: An updated overview
by: Zhinian Wu, et al.
Published: (2023-06-01)
by: Zhinian Wu, et al.
Published: (2023-06-01)
Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis
by: Tomoko Tadokoro, et al.
Published: (2024-05-01)
by: Tomoko Tadokoro, et al.
Published: (2024-05-01)
Portal Vein Web: A Rare Cause of Extrahepatic Portal Vein Obstruction in a Child
by: Benjamin Chacko, et al.
Published: (2025-05-01)
by: Benjamin Chacko, et al.
Published: (2025-05-01)
Causes for the absence of thrombocytopenia in patients with liver cirrhosis and portal vein thrombosis: A case-control study
by: Maria Y. Nadinskaia, et al.
Published: (2023-10-01)
by: Maria Y. Nadinskaia, et al.
Published: (2023-10-01)
Magnetic Resonans Imaging Of Intrapancreatic Collaterals in Portal Vein Thrombosis With And Without Cirrhosis
by: Nuray Haliloğlu, et al.
Published: (2013-08-01)
by: Nuray Haliloğlu, et al.
Published: (2013-08-01)
Case report: Primary myelofibrosis presenting with portal hypertension mimicking cirrhosis
by: Xiayu Gan, et al.
Published: (2024-05-01)
by: Xiayu Gan, et al.
Published: (2024-05-01)
Extrahepatic portal vein obstruction with portal cavernoma transformation in a child
by: Ravikanth Reddy
Published: (2021-01-01)
by: Ravikanth Reddy
Published: (2021-01-01)
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis
by: Anja Tiede, et al.
Published: (2025-01-01)
by: Anja Tiede, et al.
Published: (2025-01-01)
Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review
by: Jiangyu Yan, et al.
Published: (2021-12-01)
by: Jiangyu Yan, et al.
Published: (2021-12-01)
Arab Social Sciences Portal
by: Editorial Board
Published: (2005-03-01)
by: Editorial Board
Published: (2005-03-01)
Asian Internet Resources Portal
by: Editorial Board
Published: (2004-12-01)
by: Editorial Board
Published: (2004-12-01)
Clinical application value of CT portal venography in collateral circulation with portal hypertension
by: WU Zhe, TANG Yi, GUO Jun, SUN Hao, JIN Zheng-yu
Published: (2021-01-01)
by: WU Zhe, TANG Yi, GUO Jun, SUN Hao, JIN Zheng-yu
Published: (2021-01-01)
Aggravation of hepatic encephalopathy after portosystemic shunting interventions (TIPS procedure) for complicated portal hypertension
by: Yu. V. Khoronko, et al.
Published: (2018-03-01)
by: Yu. V. Khoronko, et al.
Published: (2018-03-01)
A Rare Case of Portal Vein Thrombosis Due to Portal Vein Aneurysm. Case Report and the Review of the Literature
by: J. Arudchelvam
Published: (2024-12-01)
by: J. Arudchelvam
Published: (2024-12-01)
Making Sense of Belonging: Translocal Subjectivity and Rootedness of Turkish-Born Women in Sweden
by: Merve Tunçer
Published: (2023-06-01)
by: Merve Tunçer
Published: (2023-06-01)
Gastric Variceal Bleeding In Patients of Liver Cirrhosis With Portal Hypertension
by: Muhammad Fahad Zakir, et al.
Published: (2024-06-01)
by: Muhammad Fahad Zakir, et al.
Published: (2024-06-01)
Fibrosis Progression in Patients with Budd–Chiari Syndrome and Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Long-Term Study Using Transient Elastography
by: Martin Rössle, et al.
Published: (2024-02-01)
by: Martin Rössle, et al.
Published: (2024-02-01)
External Respiratory Function Changes in Liver Cirrhosis with Different Types of Portal Blood Flow
by: B. N. Levitan, et al.
Published: (2012-03-01)
by: B. N. Levitan, et al.
Published: (2012-03-01)
Similar Items
-
Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
by: Lukas Sturm, et al.
Published: (2022-01-01) -
Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis
by: Kseniya Gulyaeva, et al.
Published: (2025-03-01) -
Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis
by: Ping Qi, et al.
Published: (2025-06-01) -
The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2012-09-01) -
Portal vein thrombosis in patients with liver cirrhosis
by: Savić Željka, et al.
Published: (2024-01-01)
